Latigo Biotherapeutics, Inc.
Company

Latigo Biotherapeutics, Inc.

Biotechnology Research Thousand Oaks, California, United States 44 employees TOWER
Employees
44
Contacts
4
Emails
4
Phones
3

Latigo Biotherapeutics, Inc. Overview

Headquarters
Thousand Oaks, California, United States
Industry
Biotechnology Research
Employees
44
Stock Symbol
TOWER
Funding
150.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.

Latigo Biotherapeutics, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Latigo Biotherapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Holly Carlisle VP, Translational Science at Latigo
Email Phone
Nima Farzan
Email Phone
Ashley Wright
Email Phone
Mike Kaufman Vice President, Head of Chemistry
Email

Compare Similar Companies to Latigo Biotherapeutics, Inc.